Published in Cancer Weekly, February 3rd, 1997
Initial animal studies performed at Baylor College of Medicine (BCM), Houston, Texas, using a chromosome 4 fragment containing a senescence gene demonstrated the ability of that gene to reduce colon and lung cancer growth at statistically significant levels.
Lark Technologies has been collaborating with Dr. Olivia Pereira-Smith, BCM, to identify, sequence, and functionally test candidate genes in cell line assays to establish the four senescence genes. The candidate gene from the chromosome 4 fragment was sequenced by Lark and is being tested.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.